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A B S T R A C T   
Sterilization is a quite challenging step in the development of novel polymeric scaffolds for regenerative med-
icine since conventional sterilization techniques may significantly alter their morphological and physicochemical 
properties. Supercritical (sc) sterilization, i.e. the use of scCO2 as a sterilizing agent, emerges as a promising 
sterilization method due to the mild operational conditions and excellent penetration capability. In this work, a 
scCO2 protocol was implemented for the one-pot preparation and sterilization of poly(ε-caprolactone) (PCL)/ 
poly(lactic-co-glycolic acid) (PLGA) scaffolds. The sterilization conditions were established after screening 
against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) 
vegetative bacteria and spores of Bacillus stearothermophilus, Bacillus pumilus and Bacillus atrophaeus. The tran-
sition from the sterilization conditions (140 bar, 39 ◦C) to the compressed foaming (60 bar, 26 ◦C) was performed 
through controlled depressurization (3.2 bar/min) and CO2 liquid flow. Controlled depressurization/pressuri-
zation cycles were subsequently applied. Using this scCO2 technology toolbox, sterile scaffolds of well-controlled 
pore architecture were obtained. This sterilization procedure successfully achieved not only SAL-6 against well- 
known resistant bacteria endospores but also improved the scaffold morphologies compared to standard gamma 
radiation sterilization procedures.   
1. Introduction 
Regenerative medicine is a multidisciplinary field that seeks for the 
development and manufacturing of scaffolds, i.e. tridimensional syn-
thetic grafts to guide and restore the tissue growth. Scaffold-associated 
infections are a common healthcare scenario resulting in severe com-
plications. This situation can be mitigated by strengthening the aseptic 
practices and improving the methods for scaffolds sterilization (Roch-
ford et al., 2012; Li and Webster, 2017; Arciola et al., 2018). 
The sterilization treatment of medical devices must ensure a sterility 
assurance level (SAL-6) against bacterial endospores prior to their usage, 
according to the current legal framework (ISO 14937:2009, 2009; 
Rutala et al., 2008). This value expresses that the probability of viable 
microorganisms presence in a product after its sterilization must be 
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10− 6, i.e. one in a million. Bacterial endospores are non-reproductive 
forms of resistance of particular vegetative bacteria, protected with a 
thick protein coat to ensure their survival under harsh environmental 
conditions (e.g., high cell densities, extreme temperatures, drying, 
deprivation of nutrients, presence of chemical agents). This protection 
makes them virtually ubiquitous and represents a quality and health 
concern in the pharmaceutical and food industries (Checinska et al., 
2015). 
There is not a universal sterilization procedure suitable for the pro-
cessing of all types of medical devices, including scaffolds, or biological 
tissues. This scenario represents a major hurdle in the development and 
commercialization of new generation biomedical products. Conven-
tional sterilization treatments (steam/heat, ethylene oxide –EtO– and 
gamma radiation sterilization) are not suitable methods for most poly-
meric medical devices due to harsh experimental conditions, leading to 
the onset of physicochemical changes (Dai et al., 2016). Heat treatments 
are incompatible with the processing of most biodegradable polymers 
with low glass transition temperatures (Tipnis and Burgess, 2018). EtO 
treatment affects both the structural and biochemical properties of the 
treated scaffolds (Horakova et al., 2018; Zhao et al., 2019) and may lead 
to notorious changes in the drug release profiles of drug-loaded scaffolds 
(Hsiao et al., 2012). EtO residues or by-products are carcinogenic and 
mutagenic and specific limits of residual traces have been established for 
medical devices (Association for the Advancement of Medical Instru-
mentation et al., 2008), requiring tedious post-processing aeration steps 
(Shintani, 2017). Meanwhile γ-radiation is simple, rapid and effective 
against endospores, but it induces significant chemical changes in the 
polymeric scaffolds, and may affect the mechanical performance due to 
a decrease in the polymer molecular weight, thus varying the degrada-
tion rates after sterilization (Dai et al., 2016; Tipnis and Burgess, 2018). 
Supercritical CO2, scCO2, is gaining increasing attention as a sterili-
zation agent able to inactivate vegetative forms of a wide range of Gram- 
positive and Gram-negative bacteria (Ribeiro et al., 2019). The suc-
cessful inactivation of bacterial endospores has been reported with the 
incorporation of low contents of additives (e.g. hydrogen peroxide, 
ethanol, peracetic acid, and mixtures of thereof) (Dai et al., 2016; White 
et al., 2006). The mild operating conditions, the low content of additives 
required and the excellent scCO2 permeability are clear advantages for 
the sterilization of porous biomaterials for regenerative medicine pur-
poses while maintaining the initial physicochemical properties of the 
material. Particularly, the effective sterilization of starch-based aerogels 
(SAL-6), the paradigm of labile nano-structured biomaterials, was ach-
ieved with minor modifications on the resulting textural properties and 
not compromising their mechanical performance (Santos-Rosales et al., 
2019). 
Polyesters, namely poly(ε-caprolactone) (PCL) and poly(lactic-co- 
glycolic acid) (PLGA), are widely used to prepare biodegradable scaf-
folds (Deng et al., 2020; Feng et al., 2020; Go et al., 2020; Hedayati 
et al., 2020; Seddighian et al., 2021) and products from these materials 
are commercially available (Rapidsorb®, Osteomesh®, Osteoplug®). 
Their physical and mechanical properties and the degradation rate 
depend on the monomer ratio, the molecular weight and the crystallinity 
degree (Makadia and Siegel, 2011). These features allow the manufac-
ture of scaffolds with specific degradation kinetics and mechanical 
properties, matching those of the targeted damaged tissue. For instance, 
PLGA of low inherent viscosity (0.2 dL/g) is particularly interesting for 
bone regeneration, fitting the 8 to 10 weeks degradation gap but its 
weak mechanical properties restrict its use (Diaz-Gomez et al., 2016). 
On the other hand, PCL presents higher strength and resilience, which 
can be advantageous for those tissues exposed to moderate mechanical 
stress, such as tendon, cartilage and bone, but shows slow degradation 
rate (complete PCL degradation in over 24 months) (Dash and Konki-
malla, 2012). The similarity of the mechanical properties of PCL to those 
of trabecular bone has prompted the development of several grafts made 
of PCL solely or in combination with other polymers (Woodruff and 
Hutmacher, 2010). 
The plasticizing effect of scCO2 is exploited in the sc-foaming tech-
nology for the production of solvent-free PCL-based scaffolds, being 
compatible with the incorporation of thermosensitive compounds of 
interest, such as growth factors or active pharmaceutical ingredients 
(APIs) with yields close to 100% (García-González et al., 2015a; Santos- 
Rosales et al., 2020b). The scaffold structure (porosity, pore size dis-
tribution, mean pore size, pore interconnectivity) can be precisely 
controlled by modifications on the working parameters (temperature, 
pressure, soaking time and depressurization time) and the use of poro-
gens (Chen et al., 2019; Salerno et al., 2017; Santos-Rosales et al., 
2020a; White et al., 2012). However, the scCO2 sterilization of pre-
formed polyester-based scaffolds (PCL, PLGA) is not a valid post- 
processing step because the plasticizing effect of the CO2 at the sterili-
zation conditions may notably alter the internal and external architec-
ture of the medical device. These processing limitations of scCO2 
technology can be overcome if sterilization conditions compatible with 
scaffolds production by supercritical foaming are identified and both 
processes are integrated. Thus, the aim of this work was to implement 
for the first time a scCO2-based technological platform to solve the 
challenge of an integrated manufacturing of sterile biopolymer-based 
scaffolds (Fig. 1). H2O2 was used as additive that reinforces the sterili-
zation capability of scCO2 processing (Shieh et al., 2009). The sterili-
zation conditions (pressure, temperature, time and CO2 flow) were 
established after screening against both Gram-positive (Staphylococcus 
aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) 
vegetative bacteria and spores of Bacillus stearothermophilus, Bacillus 
pumilus and Bacillus atrophaeus. The effect of this two-in-one scCO2 
processing in PCL/PLGA scaffolds was evaluated in terms of physico-
chemical, morphological and mechanical properties. The outcomes were 
compared to those of the same scaffolds that underwent a conventional 
radiation sterilization (15 kGy). Residual levels of H2O2 were indirectly 
measured by incubation of the scaffolds with fibroblasts, a particularly 
sensitive cell line towards this additive (Shatrova et al., 2016). 
2. Materials and methods 
2.1. Materials 
Poly(lactic-co-glycolic acid) (PLGA) (50:50 lactic:glycolic ratio; 16 
kDa; Tg = 41.4 ◦C, amorphous) was purchased from Purac (Gorinchem, 
The Netherlands). Poly(ε-caprolactone) (PCL) in the powdered form (50 
kDa, Tm = 61.4 ◦C, 66.7% crystallinity) was supplied by Polysciences 
(Warrington, PA, USA). CO2 (purity of >99.9%) was provided by Praxair 
(Madrid, Spain). Trypticase soy broth (TSB) and trypticase soy agar 
(TSA) media were purchased from BIOKAR Diagnosis (Pantin, France) 
Fig. 1. Scheme of the developed supercritical CO2-based technological plat-
form for the manufacture of sterile polymeric bone scaffolds. 
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and hydrogen peroxide 30% (v/v) from Sigma-Aldrich (Madrid, Spain). 
Water was purified using reverse osmosis (resistivity > 18 MΩ⋅cm, 
MilliQ, Millipore, Madrid, Spain). Sterilization reel was purchased from 
E-line S.r.l. (Torre Pallavicina, Italy). 
2.2. Development of the supercritical sterilization method 
2.2.1. Efficacy of the scCO2 sterilization treatment against vegetative 
bacteria 
300 mL of TSB liquid medium with an initial concentration of 108 
CFU/mL were prepared from both Gram-positive (Staphylococcus aureus 
-ATCC 25923-) and Gram-negative vegetative bacteria (Escherichia coli 
-ATCC 25922-; Pseudomonas aeruginosa -CECT 110-) in HPLC-vials pre-
viously sterilized with a perforated cap to allow the CO2 diffusion. Vials 
were placed in triplicate into thermally sealed sterilization pouches. 
Afterwards, the vials were located in a stainless-steel autoclave of 600 
mL (NovaGenesis, NovaSterilis Inc., Ithaca, NY, USA) with the respec-
tive amount of additive (600 ppm of H2O2). The system was heated to 
37 ◦C and pressurized at a constant rate of 20 g/min until 140 bar. 
Depending on the trial (Table 1), the setup was maintained in the batch 
mode for 1 to 4.5 h and depressurized (2–4 bar/min) until reaching 
atmospheric pressure. Once the system was depressurized, the vials were 
collected and 1 mL of each vial was plated onto TSA medium to quantify 
the reduction of the initial bioburden. After 24 h of incubation at the 
optimal temperature (37 ◦C), the counting of the microbial colony 
growth (CFUs/mL) was performed. 
2.2.2. Efficacy of the scCO2 sterilization treatment against spores 
Commercial spore strips with 106 spores of Bacillus stear-
othermophilus (ATCC 7953) and Bacillus pumilus (ATCC 27142) were 
purchased from Sigma-Aldrich, Inc. (Madrid, Spain). Bacillus atrophaeus 
(cell line 9372) spores were obtained from Crosstex International, Inc. 
(Rush, NY, USA). These three microorganisms are the biologicals in-
dicators used in steam and hydrogen peroxide vapor sterilizations (ISO 
17665–1:2006, 2006), γ-radiation sterilization (ISO 11137–1:2006/ 
Amd.1:2013, 2013) and ethylene oxide or dry heat sterilization (ISO 
11135:2014, 2014), respectively. The spore strips were sealed and 
placed in a 100-mL stainless steel autoclave (Thar Process, Pittsburg, PA, 
USA) equipped with a top agitation system (700 rpm), including 
different amounts of H2O2 as additive (600 or 1200 ppm of H2O2). The 
autoclave was then heated to 39 ◦C and pressurized until 140 bar at a 
constant pressurization rate of 13.3 bar/min. Depending on the assay, 
the system was maintained in batch mode or combined with a contin-
uous flow of CO2 at 5 g/min. Finally, the system was depressurized at a 
constant venting rate of 3.2 bar/min until atmospheric pressure. The 
bacterial growth was evaluated by naked eye through turbidity tests 
after 7 and 14 days of incubation without stirring (Raypa Digital In-
cubators, Terrassa, Spain) of the strips in tubes containing 10 mL of TSB 
medium, under the corresponding recommended incubation tempera-
tures (37 ◦C for B. pumilus and B. atrophaeus, and 60 ◦C for 
B. stearothermophilus). In addition, the absence of growth was confirmed 
by seeding 1 mL of the medium after 7 and 14 days in TSA plates. 
2.3. One-pot supercritical CO2 sterilization and foaming 
PCL and PLGA (1:1 wt ratio) in the powdered form were manually 
mixed using a spatula (1 g) in cylindrical Teflon molds (L: 24.6 mm, D: 
17 mm) (Brand GmbH, Wertheim, Germany), and then compacted with 
an aluminum plunger. The filled molds were then placed in the same 
supercritical equipment used in the spore sterilization assays (see Section 
2.2.2) and subjected to sterilization conditions (test #6, Table 2). The 
transition from the sterilization conditions (140 bar, 39 ◦C) to the 
compressed foaming parameters (60 bar, 26 ◦C), was performed through 
a controlled depressurization (3.2 bar/min) followed by a flow (20 g/ 
min) of liquid at 4 ◦C during 15 min to cool down the vessel to 26 ◦C 
(Garcia-Gonzalez et al., 2015b). The system was maintained at 60 bar 
and 26 ◦C for 1 h. Afterwards, the pressure was reduced to 38 bar at a 
constant flow rate of 20 bar/min, then by the addition of liquid CO2 the 
pressure was raised again to 60 bar. These depressurization/pressuri-
zation cycles were performed 3 times. Lastly, the system was depres-
surized to ambient pressure at a venting rate of 20 bar/min. A magnetic 
stirrer was placed at the bottom of the autoclave (not in contact with 
samples) and maintained constant at 700 rpm during the process. A 
general scheme of the pressure profile of the method is depicted in Fig. 2. 
Scaffolds in the form of solid porous cylinders were collected from the 
autoclave, labeled and stored for further characterization. 
2.4. γ-sterilization of scaffolds 
To compare the effects of the scCO2 sterilization treatment, scaffolds 
manufactured according the same procedure as in Section 2.3 but in 
absence of the H2O2 additive (unsterile) were packed in individual 
containers, and then they were γ-irradiated (Ob-Servo Ignis 06, Institute 
of Isotopes Co., Ltd. (IZOTOP), Budapest, Hungary) at 4.8 kGy/h using a 
60Co source to reach a total dose of 15 kGy. 
2.5. Scaffold characterization 
2.5.1. Structural and physicochemical characterization 
Micrographs of the scaffolds were obtained by scanning electron 
microscopy (FESEM, ULTRA PLUS, Zeiss, Oberkochen, Germany). 
Bulk density values (ρbulk) were calculated from the dimensions and 
weight of the manufactured scaffolds. The skeletal density (ρskel) was 
determined using a helium-pycnometer (Quantachrome, Boynton 
Beach, FL, USA) at room temperature (25 ◦C) and 1.01 bar (six repli-







× 100 (1) 
Relative molecular mass data of polymer samples were obtained by 
gel-permeation chromatography (GPC) using a differential refractive- 
index detector (Waters Model 410, USA) with serial Styragel columns 
from Waters (HR 6, HR 4, HR 3, HR 1 and HR 0.5), which covered from 
0 to 1.0⋅107 Dalton of effective molecular weight, as specified by the 
manufacturer. The analysis was done at 40 ◦C using tetrahydrofuran 
(THF) at a flow rate of 1 mL/min as mobile phase and a sensibility of 32. 
A 100-μL sample of each solution was injected into the system and data 
collection and analysis were performed using Breeze software® (Waters, 
Milford, MA, USA). 
Nine polystyrene standards with low polydispersity (2.8–8.6⋅106 
KDa, Toyo Soda, Japan) were used to elaborate a third calibration curve 
(Log Mol Wt = 145–11.6⋅V+0.319⋅V2− 0.00297⋅V3; R2 = 0.976; stan-
dard error = 0.217). 
Polymer samples of 0.8 mg/mL were prepared by direct dissolution 
in the mobile phase at 40 ◦C with continuous magnetic stirring and 
Table 1 
Supercritical sterilization trials of bacteria suspensions at 37 ◦C and 140 bar. The 
efficacy of the process was reported as logarithmic reduction of the initial mi-
crobial burden (logR).  







108 CFU/mL 1 600 ppm 
H2O2 
5 
108 CFU/mL 4.5 600 ppm 
H2O2 
8 
Escherichia coli 108 CFU/mL 1 600 ppm 
H2O2 
8 





108 CFU/mL 4.5 600 ppm 
H2O2 
8  
V. Santos-Rosales et al.                                                                                                                                                                                                                        
International Journal of Pharmaceutics 605 (2021) 120801
4
analyzed during the same day. Relative molecular mass of polymer 
samples was calculated based on the calibration curve using the 
abovementioned software. To calibrate the system and monitor its per-
formance, a polystyrene standard of 10.2⋅104 Da was analyzed daily. 
2.5.2. Mercury intrusion porosimetry (MIP) analyses 
MIP analyses of the scaffolds were performed (Autopore IV 9500 
model, Micromeritics, Norcross, GA, USA) at working pressures ranging 
from 0.07 to 1800 bar to determine their pore size distributions. Porosity 
values (εMIP) were determined from the intruded volume of mercury 
(VpMIP) in the scaffolds with the increase of pressure using the Washburn 
equation (Ho and Hutmacher, 2006). 
2.5.3. Mechanical properties 
Scaffolds (in duplicate) were subjected to unidirectional cyclic 
compression tests (five times) in a tensile bench with a 30 kg load cell 
(TA.XTPlus, Stable Micro Systems, Ltd., Godalming, UK) at a crosshead 
speed of 1 mm/min. Each compression cycle was performed up to a 
maximum strain of ca. 20%. All the experiments were performed at 
room temperature (25 ◦C), atmospheric pressure and 45% relative hu-
midity. Elastic deformation was expressed in percentage and calculated 
from the ratio between the initial height and the height of the sample 
bearing the highest applied physical stress. The Younǵs modulus (E) was 
calculated from the stress–strain plots previous conversion to engi-
neering stress and engineering strain. 
2.6. Cytotoxicity tests 
Murine fibroblast (CCL-163, ATCC, USA) were employed to evaluate 
the cytotoxicity of the treated scaffolds, according to ISO 10993–5:2009 
standard (ISO 10993–5:2009, 2009). H2O2 is highly toxic to fibroblast 
and its presence in a residual content absorbed on the scCO2-PCL/PLGA 
scaffolds was evaluated using two different strategies. 
In one method, scaffolds were put in contact with cells and cyto-
toxicity was evaluated at 24 and 72 h. Briefly, cells were seeded in 24- 
well plates (20,000 cells/well) with 0.5 mL of culture medium of 
DMEM supplemented with 10% FBS and 1% penicillin (10,000 UI/mL)/ 
streptomycin (10,000μ g/mL). Cells were maintained at 37 ◦C in a hu-
midified atmosphere enriched with 5% CO2 for 6 h to allow their 
attachment to the bottom of the well. Cubic scaffold pieces of 50 mg 
were incubated with cells in quintuplicate for 72 h at the former con-
ditions. Controls included cells incubated without material (negative 
control) and cells incubated with PCL/PLGA scaffolds sterilized by 
soaking in EtOH 70% for few minutes, followed by PBS washes (positive 
control). 
The second method involved the incubation of the scaffolds with the 
complete medium to allow the diffusion of any H2O2 residues trapped in 
the polymeric matrix. Scaffold pieces (50 mg; n = 5) were put in 24-well 
plates with 1 mL of culture medium and incubated for 72 h at 37 ◦C in a 
humidified atmosphere with 5% CO2. Eluates of 200 μL were removed at 
24, 48 and 72 h and seeded in 96-well plates containing the fibroblast 
(30,000 cells/cm2). The removed supplemented medium was not 
replaced to avoid a dilution effect of the cytotoxic potential of H2O2 
residues. Controls included cells incubated with eluates from PCL/PLGA 
scaffolds sterilized by soaking in EtOH (positive control) and culture 
medium (negative control). 
Cell proliferation was evaluated using the cell counting kit-8 (CCK-8) 
(Roche, Switzerland) at the sampling times and performed according to 
the manufacturer protocol. Absorbance was read at the wavelength of 
450 nm (UV BioRad Model 680 microplate reader, Hercules, CA, USA). 
Experiments were carried out in quintuplicate and the cell viability (%) 
calculated as follows: 
Cell viability (%) =
Absexp
Absnegative control
× 100 (2)  
2.7. Statistical analysis 
All results were expressed as mean ± standard deviation. Statistical 
analyses of the morphological, mechanical and cytocompatibility results 
(1-way ANOVA) were performed using Statistica v8.0 software (StatSoft 
Inc., Tulsa, OK, USA) followed by the post hoc Tukey HSD multiple 
Table 2 
ScCO2 sterilization tests against bacterial endospores at 39 ◦C and 140 bar and the achieved inactivation degree. Notation: Y denotes that SAL-6 levels were reached.  
Test Operating mode Timea (h) H2O2 content (ppm) SAL-6 for B. stearothermophilus SAL-6 for B. pumilus SAL-6 for B. atrophaeus 
#1 Static 2.5 600 – – Y 
#2 Static 5 600 Y – Y 
#3 Static 5 1200 Y Y Y 
#4 Static 2.5 1200 Y Y Y 
#5 Combined 5 (2.5 + 2.5) 1200 Y Y Y 
#6 Combined 3 (2 + 1) 1200 Y Y Y  
a In the parenthesis, the first term is the time maintained in static mode and the second term is the time under CO2 flow. 
Fig. 2. Scheme of the experimental procedure to integrate the sterilization of the material (first part) and the controlled foaming (second part).  
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comparison test. 
3. Results and discussion 
3.1. Screening of operating conditions for inactivation of vegetative and 
endospore bacterial forms 
The one-pot sterilization and foaming of polymer scaffolds required 
first the identification of sterilization conditions that can provide SAL-6 
while still being compatible with the polymer processing. The sterilizing 
effect of the scCO2 relies on a combination of multiple mechanisms of 
varying relevance in the inactivation of microorganisms. Among them, 
the acidification of cytoplasm and further damage of the cell envelope 
may play a major role in the inactivation mechanism of scCO2, which are 
favored by CO2 solubilization in the aqueous medium containing the 
bacteria (Ribeiro et al., 2019). CO2 is also able to extract lipids from the 
cell envelope (Kamihira et al., 1987; Sahena et al., 2009). scCO2 acts as a 
sterilizing agent by itself, but also as a solvent that enhances the biocidal 
function of additives like H2O2 in the inner parts of the sterilized ma-
terials (Hâncu et al., 2002). 
Initial sterilization tests were performed on vegetative forms of both 
Gram-positive (S. aureus) and Gram-negative (E. coli, P. aeruginosa) 
bacteria with scCO2 and in the absence of additives. The pathogens were 
selected regarding their high incidence as etiological agents of medical 
device-associated infections once implanted (Johnson and García, 
2015). Mild temperature (37 ◦C) and moderate pressure (140 bar) for 
short soaking times (1 h) were enough to achieve a complete reduction 
(SAL-8) on the suspensions containing E. coli without the presence of 
additives. However, the reduction achieved for S. aureus was only of 
SAL-5 under these conditions. These results are related to the fact that 
the bacterial cell walls (in terms of composition and thickness) of Gram- 
positive and Gram-negative bacteria are different. For instance, the 
peptidoglycan layer is much thinner in Gram-negative species, which 
facilitates the scCO2 diffusion, and thus accelerates the acidification of 
the cell cytoplasm (Zhang et al., 2006c). In this context, Gram-negative 
bacteria were more easily inactivated with the CO2 treatment (Table 1). 
The incorporation of low H2O2 contents (600 ppm; Table 1) 
enhanced the sterilization efficacy against S. aureus, but the obtained 
bioburden reductions were similar to pure scCO2. This effect can be 
attributed to the water contained in the liquid TSB, which can be indi-
rectly acting as a sterilization additive. 
The contact time with scCO2 was identified as the crucial factor 
influencing the antimicrobial effect, and 4.5 h were required for the 
complete inactivation of S. aureus under 600 ppm of H2O2. Under these 
conditions, the complete inactivation of vegetative forms of 
P. aeruginosa was also successfully achieved (SAL-8) (Fig. 3). 
Conventional sterilization methods are validated against a biological 
indicator, which is the bacterial spore strip more resistant to the pro-
cedure. To date, there is not an international standard to be used as 
biological indicator of scCO2 sterilization, encouraging the use of those 
from the standard sterilization procedures (steam, radiation and 
ethylene oxide) (Table 2), where the absence of bacterial growth implied 
a reduction of 106 (SAL-6). The efficacy of the supercritical sterilization 
treatment was thus assessed against the three commercial bioindicators. 
The use of agitation during the supercritical trials was needed for the 
full inactivation of endospores. Agitation ensured a homogeneous dis-
tribution of H2O2 within the autoclave. An increase of 2 ◦C in the 
working temperature was required to inactivate bacterial endospores 
under 140 bar. 
B. atrophaeus spores were the most sensitive towards the scCO2 
treatment among the tested biological indicators. Under low H2O2 
concentrations (600 ppm), less than 3 h were required to achieve a 
complete inactivation of B. atrophaeus spores (test #1, Table 2). Differ-
ently, the other bioindicators grew in the first 24 h post-treatment. The 
resistance of B. atrophaeus towards scCO2 sterilization in presence of 
H2O2 was already reported to be lower than that exhibited by other 
Bacillus genus species (Zhang et al., 2006a, 2006b). At the same additive 
content (600 ppm), longer soaking times (5 h) were enough to accom-
plish a SAL-6 for B. stearothermophilus spores (test #2, Table 2). Finally, 
higher additive contents (1200 ppm) were required to reach SAL-6 for 
B. pumilus spores (test #3, Table 2). Lower exposure time (2.5 h) also 
caused total inactivation of the three spore strains (test #4, Table 2). 
Since the resistance of B. pumilus spores was superior to the rest of the 
tested biologicals indicators, B. pumilus strain is proposed as the bio-
logical indicator of reference to evaluate the efficacy of sc-sterilization 
treatment. 
Moreover, remnants of liquid H2O2 were detected when the auto-
clave was opened after static sterilization tests (tests #1–4, Table 2). 
Fig. 3. TSA plates highlighting the complete reduction (bottom pictures) of the initial microbial burden of S. aureus, P. aeruginosa and E. coli after the supercritical 
CO2 sterilization at 37 ◦C and 140 bar in the presence of 600 ppm of H2O2 as additive. For the sake of comparison, the bacterial mantle formed when 108 CFUs/mL 
are seeded in the plate is provided (top pictures). 
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Traces of H2O2 in the sterilized materials can cause patient discomfort or 
even toxicity (Mahaseth and Kuzminov, 2017; Nichols et al., 2019); 
thus, post-processing steps (e.g. aeration) are usually required when 
treating biomaterials (Gülden et al., 2010). To solve this drawback, a 
dynamic process consisting on the combination of a batch mode with 
subsequent CO2 flow was implemented. Under these conditions, SAL-6 
was achieved against the biological indicators and no residual H2O2 
was detected within the autoclave (tests #5 and #6, Table 2). 
Overall, the sterilization efficacy of the presented scCO2-based 
methods relies on the synergistic effect of CO2 and the additive. A sig-
nificant softening of the working parameters (temperature, pressure and 
soaking time) to achieve SAL-6 against dry spores with respect to the 
literature (Donati et al., 2012; Shieh et al., 2009; Zhang et al., 2006a, 
2006b) has been achieved. In addition, the absence of additive at the end 
of the sterilization procedure may pave the way towards its imple-
mentation for routine biomaterial sterilization. The optimum experi-
mental conditions in terms of sterilization efficacy, economy of the 
process, and absence of residual H2O2 in the autoclave were identified as 
those corresponding to test #6 (Table 2). 
3.2. Sterilization and foaming integration process 
The optimized scCO2 sterilization method (test #6, Table 2) was 
adapted for the production of sterile PLGA/PCL foamed scaffolds in a 
one-pot integrated process (see section 2.3). This approach was devel-
oped for the foaming of polymers of low inherent viscosity (0.2 dL/g), 
which is still technologically challenging (Diaz-Gomez et al., 2016). The 
transition from the sterilization parameters of pressure and temperature 
to those of foaming was performed by a controlled depressurization and 
a fast cooling of the autoclave, respectively. The depressurization step of 
the foaming process strongly determines the foam formation (Di Maio 
and Kiran, 2018), and the polymer mixture used in this work may suffer 
an unconstrained pore expansion leading to a loss of physical integrity if 
the depressurization is not precisely controlled. Firstly, the pressure was 
reduced up to 60 bar, since below this threshold the polymer expansion 
was uncontrolled, according to preliminary foaming results (data not 
shown). The temperature transition from 39 to 26 ◦C was critical to 
control the polymer matrix expansion, and the use of a liquid CO2 flow 
resulted in a fast and efficient approach to cool down the autoclave. 
After the cooling step, the system was maintained for 1 h at 60 bar to 
reach stable CO2 sorption levels in the polymeric mixture. To force the 
polymer vitrification and restrict the foam expansion, depressurization/ 
pressurization cycles were performed during the depressurization step 
to further cool down the autoclave, as previously reported (Goimil et al., 
2018). 
Following the proposed procedure, the polymer expansion was pre-
cisely controlled and sterile lightweight foams were manufactured 
(scCO2-PCL/PLGA in Table 3). Overall, homogeneous and highly porous 
scaffolds (>71%) were obtained (Fig. 4), matching those of trabecular 
bone (Dwivedi et al., 2020; Wang et al., 2020). SEM images unveiled the 
presence of a family of interconnected large (>100 µm) pores sur-
rounded by smaller pores. Although the optimal pore size in scaffolds for 
long bone regeneration is above 300 µm (Abbasi et al., 2020; Lee et al., 
2019), smaller pores have been demonstrated to play a beneficial role in 
the mechanical performance, ultimately leading to favorable in vivo 
tissue repair in critical calvarial defects using a rat model (Wang et al., 
2020). The porosity determined by mercury intrusion porosimetry (εMIP) 
was clearly different to the overall porosity values, with a rough 
decrease of 50% (Table 3). By the MIP-method performed in this work, 
only open pore populations in the 0.01–180 µm range were measured. 
The presence of closed pores or pores larger than the upper limit (>180 
µm) were responsible for these divergences. 
3.3. Effect of the sterilization technique on the scaffold properties 
The influence of the sterilization techniques on the structural prop-
erties of the manufactured scaffolds was evaluated. Particularly, scCO2 
sterilization was compared to a standard technique (γ-irradiation). In 
addition, the following controls were produced and evaluated: unsterile 
scaffolds (negative controls) were manufactured applying the steriliza-
tion/foaming integrating process but in absence of H2O2 (PCL/PLGA, in 
Table 3). Some of these scaffolds were further subjected to a standard 
gamma radiation method of 15 kGy (Nguyen et al., 2011) and consid-
ered as positive controls (γ-PCL/PLGA, in Table 3). 
Scaffolds subjected to the γ-radiation treatment experimented a 
significant densification (p < 0.05), reducing the overall porosity values 
by ca. 10% with respect to unsterile scaffolds. The smaller pore popu-
lation (<180 μm) was particularly affected by this densification, since 
the decrease in the εMIP directly correlates with the overall porosity 
reduction (Table 3). This effect can restrict the use of γ-sterilization 
procedures for polymeric scaffolds, since small pores play a major role in 
increasing the surface area and enhancing cell colonization (Jodati et al., 
2020). 
Irradiated scaffolds underwent a remarkable decrease in Mw and Mn 
(GPC data in Table 3), indicating that the γ-sterilization procedure 
degraded the polymers shortening their chains (Cottam et al., 2009; 
Holy et al., 2000). The significant reduction on the molecular weight 
observed for the γ-irradiated scaffolds was mainly attributed to the 
PLGA degradation, since decreases of 50–70% were previously reported 
for this biopolymer depending on the irradiated dose (Holy et al., 2000; 
Shahabi et al., 2014). These significant changes in the polymer at the 
irradiated dose (15 kGy) discouraged the gamma irradiation for the 
sterilization of the manufactured scaffolds. It should be noted that the 
tested irradiation dose was already below the standard value (25 kGy). 
Thus, although lower doses could preserve the physicochemical prop-
erties of the scaffolds, their sterility might be jeopardized (Bosworth 
et al., 2012). 
Remarkably, when the scCO2 sterilization/foaming procedure was 
applied, the resulting scaffolds were morphologically identical to their 
unsterile counterparts (Table 3). The H2O2 addition slightly favored the 
expansion of the foams during the manufacturing, although no statisti-
cally significant differences in densities were detected compared to the 
untreated material. Supercritical sterilization had no impact in the 
chemical properties of the polymeric mixture since identical molecular 
weights (Mw, Mn) to the unsterile scaffolds were obtained by GPC 
analysis (Table 3). 
Mechanical evaluations showed that the scaffolds maintained their 
physical integrity and cracks were not formed during the compression 
test. Scaffolds had an elastoplastic behavior during the compression 
cycles with permanent deformation (Fig. S1). The structures became 
stiffer after several uniaxial stress cycles with a 20% increase in the 
Young’s moduli after 5 cycles (Table 4) and being suitable for the 
intended application (Athanasiou et al., 2000). No statistical differences 
were observed in the mechanical properties between scaffolds, 
Table 3 
Physicochemical properties of PCL/PLGA scaffolds subjected to sterilization treatments (γ-sterilization; scCO2 sterilization) compared to untreated scaffolds. Equal 
letters denote statistically homogeneous groups (1-way ANOVA, p < 0.05, and post hoc Tukey HSD multiple comparison test).   
ρbulk (g/cm
3)  ρskel (g/cm
3)  ε (%)  εMIP(%)  VP (cm3/g)  Mw (kDa) Mn (kDa) PD 
PCL/PLGA 0.308 ± 0.018a 0.998 ± 0.008 69.1 ± 1.8a 31.1 2.25 80.9 18.0 4.5 
γ-PCL/PLGA  0.390 ± 0.023b 0.974 ± 0.004 60.0 ± 2.4b 23.2 1.54 27.8 12.2 2.3 
scCO2-PCL/PLGA 0.289 ± 0.011a 1.000 ± 0.012 71.1 ± 1.2a 30.0 2.46 81.8 21.5 3.8  
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regardless of the sterilization treatment performed. 
Despite the reduction on the molecular weight of γ-irradiated scaf-
folds, the mechanical behavior was unaltered compared to untreated 
foams. The reduction on the molecular weight of PLGA upon γ-irradia-
tion did also not show any effect on the mechanical performance of 
solely PLGA scaffolds (Davison et al., 2018). On the other hand, a 
standard γ-irradiation procedure (25 kGy) on PCL scaffolds was reported 
to induce an increase in molecular weight due to cross-linking of poly-
mer chains, ultimately increasing the yield stress (Cottam et al., 2009). 
These effects of radiation on the chemical structure of the polymers may 
counteract any change in the mechanical performance. 
3.4. Cytotoxicity tests of scCO2 sterilized/foamed PCL/PLGA scaffolds 
The presence of residual H2O2 absorbed in the sterile PCL/PLGA 
scaffolds produced under the most adequate conditions (test #6, 
Table 2) was indirectly assessed using fibroblasts. Cytotoxicity derived 
from H2O2 concentrations in cell culture can strongly vary with the cell 
line, incubation time and cell density (Gülden et al., 2010). Intracellular 
H2O2 concentrations above 1 µM are known to induce an oxidative stress 
to the cells, ultimately leading to death (Stone and Yang, 2006). The 
proposed dynamic step with CO2 flow during the sterilization/foaming 
procedure reduced the presence of the additive on the individually 
packed sterile scaffolds up to non-toxic levels. 
scCO2-PCL/PLGA scaffolds exhibited outstanding viability values, 
regardless of the experimental method used (Fig. 5). A slightly yellowish 
coloration on the medium containing the scaffolds was observed and 
attributed to an acidification due to PLGA degradation. Nevertheless, 
cells directly incubated with scaffold pieces presented a good 
morphology with cell viability values close to those obtained for the 
controls. Cells incubated for 24 h in the presence of scCO2-PCL/PLGA 
scaffolds had the lowest viability values (p < 0.05), although the 
viability was still above 80%. After 72 h of direct contact of scaffolds 
with fibroblasts, there were no significant differences in the cell viability 
values either from controls or EtOH sterilized scaffolds (Fig. 5A). Cells 
incubated with the scaffolds eluates also presented an appropriate shape 
and grew in the same extent or even more than the controls along the 
three tested time periods (24, 48 and 72 h) (Fig. 5B). 
4. Conclusions 
An integrated sterilization/foaming procedure for scaffold 
manufacturing based on the use of scCO2 technology is herein firstly 
reported. Sterile PCL/PLGA scaffolds were obtained, meeting the 
morphological and mechanical criteria to be used as bone graft sub-
stitutes. The method allowed for an excellent morphological control and 
preserved the chemical identity of foams containing PLGA of low 
inherent viscosity (0.2 dL/g), a technologically challenging polymer. 
Despite the H2O2 addition and absence of post-processing aeration steps, 
no cytotoxicity was observed in the resulting scaffolds once incubated 
with fibroblasts, a particularly sensitive cell line versus this additive. 
Differently, the gamma sterilization procedure (15 kGy) led to signifi-
cant structural and physicochemical changes, compromising the scaffold 
quality. Results place great value on the supercritical fluid technology as 
a dual (sterilizing + foaming) tool to address critical challenges of tissue 
engineering: sterilization of biomaterials and scaffold process 
Fig. 4. Images of PCL/PLGA scaffolds produced by the one-pot sterilization/foaming method. Scale bars: 5 mm (white) and 100μ m (black).  
Table 4 
Compressive mechanical properties of PCL/PLGA scaffolds after being subjected 
to the sterilization treatments (γ-sterilization; scCO2-sterilization) compared to 
untreated scaffolds.  
Scaffold Compression Cycle Young’s Modulus (MPa) 
PCL/PLGA 1 6.73 ± 0.46 
5 7.32 ± 0.34 
γ-PCL/PLGA  1 6.29 ± 0.50 
5 7.09 ± 0.36 
scCO2-PCL/PLGA 1 6.35 ± 0.24 
5 7.91 ± 0.61  
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integration. These translational results will be further tested in an in vivo 
animal model regarding bone repair. Finally, spores of the B. pumilus 
strain are proposed as the biological indicator of reference to assess 
scCO2-based sterilization methods. 
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Concheiro, Angel, Domingo, C., Alvarez-Lorenzo, C., 2017. Synthetic scaffolds with 
full pore interconnectivity for bone regeneration prepared by supercritical foaming 
using advanced biofunctional plasticizers. Biofabrication 9, 035002. 
Santos-Rosales, V., Ardao, I., Alvarez-Lorenzo, C., Ribeiro, N., Oliveira, A., García- 
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